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Abstract  30 
Glucocorticoid signaling is context-dependent, and in certain scenarios glucocorticoid receptors (GR) 31 
are able to engage with other members of the nuclear receptor subfamily. Glucocorticoid signaling 32 
can exert sexually dimorphic effects, suggesting a possible interaction with androgen sex hormones. 33 
We therefore set out to determine the crosstalk between glucocorticoids and androgens in 34 
metabolic tissues including white adipose tissue, liver and brown adipose tissue. Thereto we 35 
exposed male C57BL/6J mice to elevated levels of corticosterone in combination with an androgen 36 
receptor (AR) agonist or an AR antagonist. Systemic and local glucocorticoid levels were determined 37 
by mass spectrometry, tissue expression of glucocorticoid-responsive genes and protein was 38 
measured by RT-qPCR and Western blot, respectively. To evaluate crosstalk in vitro, cultured white 39 
and brown adipocytes were exposed to a combination of corticosterone and an androgen agonist. 40 
We found that AR agonism potentiated transcriptional response to GR in vitro in white and brown 41 
adipocytes and in vivo in white and brown adipose tissue. Conversely, AR antagonism substantially 42 
attenuated glucocorticoid signaling in white adipose tissue and liver. In white adipose tissue this 43 
effect could partially be attributed to decreased 11B-hydroxysteroid dehydrogenase type 1-44 
mediated glucocorticoid regeneration upon AR antagonism. In liver, attenuated GR activity was 45 
independent of active glucocorticoid ligand levels. We conclude that androgen signaling modulates 46 
GR transcriptional output in a tissue-specific manner.  47 
Word count abstract: 216  48 
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Introduction 49 
Glucocorticoids are adrenal steroid hormones engaged in a myriad of functions including adaptation 50 
to stress, circadian function and immune regulation. Glucocorticoids also mediate quintessential 51 
processes in metabolic physiology to ensure whole-body energy homeostasis e.g. by stimulating 52 
hepatic gluconeogenesis, reducing peripheral glucose uptake and inducing adipose tissue lipolysis 53 
(Kadmiel and Cidlowski 2013). Due to the pleiotropic nature of glucocorticoid signaling, 54 
dysregulation inevitably endangers metabolic health. This is seen in Cushing’s syndrome, where 55 
glucocorticoid excess causes massive accumulation and redistribution of energy stores, accompanied 56 
by cardiometabolic harm (Morgan, et al. 2016).  57 
Glucocorticoid action in metabolism is predominantly mediated by glucocorticoid receptors (GR) 58 
which are expressed in virtually all tissues in both humans and rodents. It is known that 59 
glucocorticoid transcriptional activity is subject to multiple levels of regulation; from the production, 60 
secretion and tissue uptake/export of steroid ligands to receptor expression and DNA-binding. 61 
Intracellular enzymatic (in)activation controls glucocorticoid activity, i.e. 11B-hydroxysteroid 62 
dehydrogenase type 1 (11B-HSD1) catalyzes glucocorticoid regeneration from inactive steroid while 63 
11β-hydroxysteroid dehydrogenase type 2 (11B-HSD2) inactivates the active ligand pool. Active 64 
ligand binding to GR provokes its translocation from the cytoplasm to the nucleus. GR binds DNA at 65 
so-called glucocorticoid response elements thereby facilitating gene induction or repression 66 
(Ratman, et al. 2013).  67 
The extent of GR-regulated transcriptional activity is dictated by ligand availability, receptor 68 
expression and the DNA-binding site (Meijsing, et al. 2009), but also by interactions with 69 
coregulatory proteins and other (often unknown) signaling partners (Meijer, et al. 2005). 70 
Glucocorticoids therefore act in a context-dependent manner and it was previously shown that 71 
glucocorticoids can have sexually dimorphic actions (Duma, et al. 2010; Quinn and Cidlowski 2016). 72 
For example, in the liver the synthetic glucocorticoid dexamethasone differentially affects expression 73 
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of many GR target genes in male vs. female rats (Duma et al. 2010). Such sexually dimorphic effects 74 
could possibly be explained by glucocorticoid interactions with sex hormone signaling, e.g. androgen 75 
receptor (AR) activity. AR signaling is known to regulate physiological processes like adipose tissue 76 
lipolysis and hepatic glucose and lipid metabolism (Lee, et al. 2013; Shen and Shi 2015), but it is yet 77 
unclear if AR signaling can contribute to the sexually dimorphic effects of GR.  78 
In certain contexts, GRs are able to engage with other members of the steroid nuclear receptor 79 
subfamily (Chen, et al. 1997; Mifsud and Reul 2016). All six nuclear steroid receptors, including the 80 
GR and the AR, originate from a common ancestral receptor gene (Thornton 2001), which underlies 81 
the substantial homology in DNA-binding domain and hormone-response elements. For example in 82 
cancer, the chromatin binding landscape of the GR is exceptionally similar to that of other nuclear 83 
steroid receptors (Severson, et al. 2018), GR shares numerous DNA binding sites with the AR (Arora, 84 
et al. 2013), and these two receptors may even form heterodimers on glucocorticoid response 85 
elements (Chen et al. 1997). However, beyond cancer the crosstalk between GR and AR has 86 
remained elusive.  87 
In this study, we explored if crosstalk between androgens and glucocorticoids exists in metabolic 88 
tissues. In male C57BL/6J mice, we investigated possible interactions in white adipose tissue (WAT), 89 
liver, and brown adipose tissue (BAT) - all metabolically-active tissues that contribute considerably to 90 
whole-body metabolism. We reveal that androgen signaling strongly influences metabolic GR 91 
signaling, and that the underlying mechanisms are highly tissue-specific. 92 
 93 
Material and methods 94 
Animals 95 
All animal studies were approved by the ethical committee of Leiden University Medical Center. 96 
Mice were housed in conventional cages with a 12:12-hour light-dark cycle and ad libitum access to 97 
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food and water. To examine the effect of AR signaling on metabolic glucocorticoid action, 8-week old 98 
male C57BL6/J mice (Jackson Laboratory) were exposed to the GR agonist corticosterone (CORT; 99 
Sigma-Aldrich) and AR agonist dihydrotestosterone (DHT; 5α-Androstan-17β-ol-3-one, Sigma-100 
Aldrich) via subcutaneous implantation of slow-release pellets (100 mg). The AR antagonist 101 
Enzalutamide (MedChemExpress) was administered via diet-supplementation (357 mg drug per kg 102 
diet; resulting in an estimated dose of 40 mg/kg/day). The following experimental groups were 103 
followed for a period of 14 days: 1) Vehicle (N=6), 2) CORT (20 mg corticosterone; N=7), 3) 104 
CORT+DHT (20 mg corticosterone, 30 mg DHT; N=7) and 4) CORT+Enza (20 mg corticosterone + 105 
Enzalutamide-treatment; N=7). At baseline and after 14 days, body weight was measured with a 106 
scale and body composition was determined by echo-MRI. After seven days of intervention, mice 107 
were fasted for 6 hours and blood was collected for analysis of plasma triglycerides, cholesterol and 108 
free fatty acids. After 14 days mice were euthanized by CO2 inhalation, blood was drawn via heart 109 
puncture in EDTA-coated tubes, mice were perfused with ice-cold PBS for 5 min and metabolic 110 
organs (i.e. gonadal and subcutaneous WAT, liver, interscapular BAT) were collected for molecular, 111 
functional and histological analyses.  112 
To evaluate the effect of Enzalutamide alone, we performed a control experiment in which mice 113 
were treated with vehicle (N=6) or Enzalutamide (40 mg/kg/day via diet; N=6) for 27 days. At 114 
baseline and after 27 days, body weight was measured with a scale and body composition was 115 
determined by echo-MRI. Blood was collected at day 21 after a 6 hour fast, for analysis of plasma 116 
triglycerides, cholesterol and free fatty acids. After 27 days, mice were euthanized by CO2 inhalation, 117 
perfused with ice-cold PBS for 5 min and WAT and liver were collected for molecular analysis.  118 
RNA isolation, cDNA synthesis and real-time quantitative (RT)-qPCR analysis 119 
Snap-frozen tissue samples of gonadal WAT, liver and BAT were homogenized in Tripure (Roche) and 120 
mRNA was isolated according to the manufacturer’s protocol. 500-1000 ng mRNA was used for cDNA 121 
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synthesis using M-MLV reverse transcriptase (Promega), and gene expression was assessed with RT-122 
qPCR. Primer sequences are available upon request. 123 
Western blot 124 
Western blot was performed using the Wes apparatus (ProteinSimple), according to the 125 
manufacturer’s protocol. For WAT and liver samples, 2.0 and 0.8 mg/ml lysate was used, 126 
respectively. The Wes apparatus allows simultaneous detection of multiple proteins and therefore 127 
loading controls may be identical between different figures. The following primary and secondary 128 
antibodies were used: 11BHSD1 (in house antibody University of Edinburgh, 1:10), FKBP5 129 
(AB_2103136, R&D systems, AF4094, 1:70), GAPDH (AB_10167668, Santa Cruz Biotechnology, 130 
sc25778, 1:50), GR (AB_2631286, Cell signaling, 12401, 1:10), HPR anti-goat (ProteinSimple, DM006), 131 
HRP anti-rabbit (ProteinSimple, DM001) and HRP anti-sheep (AB_955452, Abcam, ab6900, 1:100).  132 
Steroid extraction and liquid chromatography-mass spectrometry (LC-MS) analysis 133 
Steroids were extracted from plasma (100 µl, obtained from heart puncture) and snap-frozen 134 
gonadal WAT and liver tissues (approx. 200 mg) and were subsequently analyzed using LC-MS. 135 
Plasma samples were diluted 1:1 with ammonium hydroxide and enriched with internal standards 136 
epicorticosterone, D4-cortisol, 13C3-testosterone and 13C3-dihydrotestosterone. Plasma samples 137 
were applied to SLE200+ columns, eluted with 95:5 DCM:isopropanol, dried down under hydrogen 138 
and reconstituted in 70 µl mobile phase (70:30 H2O:CH3CN). Liver and WAT samples were 139 
homogenized in respectively 7:2 MeOH:H2O and ethyl acetate, and were enriched with internal 140 
standards epicorticosterone and D4-cortisol. The liver homogenates were dried down under 141 
nitrogen and dissolved in 30% MeOH. The WAT homogenates were dripped into chilled EtOH:Acetic 142 
acid:H2O, sonicated for 8x15 seconds, dried down under nitrogen and reconstituted in 1:1 143 
MeOH:hexane. After inversion the MeOH layer was dried down and reconstituted in 10:1 ethyl 144 
acetate:H2O. The ethyl acetate layer was isolated and dried down after which it was resuspended in 145 
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30% MeOH. Both liver and WAT samples were applied to bond elute C18 columns (Agilent 146 
Technologies). The steroid-containing elutes were dried down and dissolved in 70 µl mobile phase 147 
(70:30 H2O:acetonitrile) for simultaneous mass spectrometry measurement of the glucocorticoids 148 
CORT and 11-dehydrocorticosterone (11-DHC), and the androgens testosterone and DHT. 149 
Cell culture 150 
Human HEK293T cells were passaged in culture medium (DMEM+Glutamax supplemented with 10% 151 
FCS and penicillin/streptomycin) and during experiments medium with charcoal-stripped serum was 152 
used. Cells were transfected using Fugene HD (Promega) with 25 ng TAT3-luciferase, 10 ng human 153 
AR or GR, 1 ng CAGGS-renilla and 100 ng pcDNA. Cells were pretreated with Enzalutamide for 30 min 154 
before agonists for AR (Testosterone or DHT) or GR (cortisol) were added. After 24 hours, firefly- and 155 
renilla-luciferase signals were measured using a dual-luciferase assay (Promega).  156 
Murine 3T3.L1 cells were passaged in culture medium (DMEM+Glutamax supplemented with 10% 157 
FCS and penicillin/streptomycin). For experiments, preadipocytes were seeded and medium was 158 
replaced every 2-3 days. After reaching confluence, adipogenic differentiation was induced by 159 
adding medium supplemented with 250 nM dexamethasone, 11 mg/ml IBMX and 10 mg/ml insulin 160 
for 2 days, medium supplemented with 10 mg/mL insulin for 6 days and normal culture medium for 161 
7 days. During the last 2 days of differentiation and during treatments FCS was replaced with 162 
charcoal-stripped serum. Cells were pretreated with 100 nM DHT and after 1 hour 10-30 nM 163 
corticosterone was added for 24 hours. Cells were harvested in Tripure for further RT-PCR analysis of 164 
GR-responsive transcripts. Murine immortalized brown adipocytes were generated and cultured as 165 
previously published (Kroon, et al. 2018) and exposure with DHT and corticosterone was identical as 166 
in 3T3.L1 cells.  167 
 168 
 169 
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Statistical analysis 170 
All data are presented as mean ± SEM. Statistical analysis were performed with GraphPad Prism 7 171 
software (GraphPad Inc.). To calculate statistical differences between more than two groups, a one-172 
way analysis of variance with Tukey multiple-comparison test was used. For direct comparison of 173 
two groups, an unpaired students t-test was performed.  174 
 175 
Results 176 
Confirmation of glucocorticoid and androgen interventions 177 
We set out to investigate the crosstalk between glucocorticoid and androgen signaling in metabolic 178 
tissues. AR agonist DHT and AR antagonist Enzalutamide were used, for which reporter assays in 179 
HEK293T cells confirmed effective AR agonism and antagonism, respectively (Fig. 1A-B). 180 
Enzalutamide did not exhibit GR cross-reactivity (Fig. 1C) (Dalal, et al. 2014). To investigate crosstalk 181 
in vivo, male C57BL/6J mice were implanted with CORT-releasing pellets (van den Beukel, et al. 182 
2015) in combination with DHT or Enzalutamide. Effective increased glucocorticoid exposure was 183 
confirmed by decreased adrenal weight (biomarker for ACTH stimulation of the adrenal cortex; Fig. 184 
1D). DHT and Enzalutamide interventions were confirmed by increased and decreased weight of the 185 
androgen-responsive seminal vesicles, respectively (Fig. 1E). In addition enhanced plasma and tissue 186 
levels of DHT in the DHT group (Fig. 1F-H) and increased plasma levels of testosterone upon 187 
Enzalutamide treatment (due to relieved negative feedback on testosterone secretion) confirm the 188 
efficacy of experimental interventions (Fig. 1I-K).  189 
AR antagonism lowers glucocorticoid-induced hyperlipidemia 190 
Elevated CORT did not influence total body weight but did alter body composition (seemingly 191 
enhanced fat mass and significantly reduced lean mass; Fig. 2A) and induced hyperlipidemia (Fig. 192 
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2B). DHT generally did not affect CORT-induced metabolic outcome, with the exception of lean body 193 
mass (Fig. 2A). Notably, concomitant AR antagonism with Enzalutamide significantly lowered 6 hour-194 
fasted plasma levels of triglycerides (p<0.01 vs CORT), cholesterol (p<0.01 vs CORT) and free fatty 195 
acids (p<0.05 vs CORT), thus alleviating CORT-induced dyslipidemia (Fig. 2B). Treatment with 196 
Enzalutamide alone did not alter body weight and composition (Fig. 2C), but did lower plasma lipid 197 
levels (Fig. 2D).  198 
AR antagonism attenuates glucocorticoid-induced transcriptional activity in a tissue-specific 199 
manner 200 
GR-regulated transcriptional activity was evaluated in multiple metabolic tissues by RT-PCR analysis 201 
of well-established glucocorticoid-responsive transcripts FK506 binding protein 5 (Fkbp5), TSC22D3 202 
(Gilz) and Metallothionein-II (Mt2a) (Arora et al. 2013; Bolton, et al. 2007; Wilson, et al. 2016). As 203 
expected CORT upregulated expression of GR-responsive genes in WAT (Fig. 3A-C), liver (Fig. 3D-F) 204 
and BAT (Fig. 3G-I). Compared to CORT alone, AR agonist DHT further enhanced expression of WAT 205 
Fkbp5 (p<0.09, Fig. 3A) and Mt2a (p<0.05, Fig. 3C), and BAT Fkbp5 (p<0.01, Fig. 3G) and Gilz (p<0.01, 206 
Fig. 3H). Interestingly, AR antagonism with Enzalutamide diminished CORT-induced GR 207 
transcriptional activity in WAT and liver (Fig. 3A-F), but did not influence GR transcriptional activity 208 
in BAT (Fig. 3G-I). Also at the protein level, CORT-induced FKBP5 content in both WAT and liver was 209 
attenuated with AR antagonism (Fig. 3J-K). Enzalutamide treatment alone did not alter GR-210 
responsive genes in WAT and liver (with the possible exception of Mt2a in liver; Fig. 3M-N), 211 
confirming that AR antagonism specifically attenuates CORT-induced GR activity. In addition to 212 
classic GR target genes, we interrogated the expression of genes involved in metabolic function: 213 
lipolysis genes hormone-sensitive lipase (Hsl) and adipocyte triglyceride lipase (Atgl) were increased 214 
after combined CORT and DHT exposure in WAT; very-low-density-lipoprotein production genes 215 
microsomal triglyceride transfer protein (Mttp) and Apolipoprotein B (Apob) in the liver were induced 216 
by CORT and attenuated by concurrent AR antagonism; while thermogenic gene Ucp1 in BAT was 217 
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unaffected by all interventions (Fig. 3L). Our data highlight the tissue-specific nature of 218 
glucocorticoid-androgen interactions and a possible effect on metabolic pathways. 219 
AR agonism potentiates GR signaling in fully differentiated murine (brown) adipocytes 220 
To further investigate the crosstalk between androgens and glucocorticoids directly on adipocytes - 221 
we utilized cell-based culture models of immortalized white and brown adipocytes. We first 222 
confirmed Nr3c1 and Nr3c4 expression in fully differentiated white and brown adipocytes (Fig. 4A-223 
B). Next, we determined the expression of GR-responsive genes after 24 hour exposure to CORT with 224 
and without a 1 hour pretreatment with DHT. CORT treatment alone resulted in a dose-dependent 225 
induction of Fkbp5, Gilz, Mt2a and Atgl in 3T3.L1 white adipocyte cells (Fig. 4C-F) and Fkbp5 in 226 
immortalized brown adipocytes (Fig. 4G). DHT on its own (100 nM) did not affect transcript levels, 227 
with the exception of Fkbp5 expression in brown adipocytes which was marginally upregulated (1.4-228 
fold induction, p<0.05, Fig. 4G). Supporting our in vivo data, combined exposure to CORT and DHT 229 
seemed to synergistically upregulate expression of Fkbp5 (p<0.05 at 30 nM CORT; Fig. 4C), Gilz 230 
(p<0.001 at 10 nM CORT; Fig. 4C) and Mt2a (p<0.05 at 10 nM CORT; Fig. 4E) in 3T3.L1 cells. CORT-231 
induced expression of lipolysis gene Atgl was not significantly increased upon DHT treatment (Fig. 232 
4F). In brown adipocytes we observed a similar potentiation for expression of Fkbp5 (Fig. 4G) and 233 
possibly Gilz (Fig. 4H) but not for Mt2a and Ucp1 (Fig. 4I-J), supporting our observations in vivo in 234 
BAT. Altogether we observe interactions between glucocorticoid and androgen signaling in vitro, as 235 
androgens exposure potentiates GR activity at physiological glucocorticoid concentrations. 236 
AR antagonism tissue-specifically alters corticosterone and 11-dehydrocorticosterone levels 237 
We attempted to decipher how AR signaling alters GR-regulated transcriptional activity. GR 238 
expression levels in WAT and liver were not causally involved: CORT downregulated GR protein 239 
expression via homologous downregulation (Dong, et al. 1988), but androgen interventions did not 240 
further affect GR expression (Fig 5A-D). To analyze if glucocorticoid turnover is affected by androgen 241 
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signaling we determined tissue-specific levels of ligand CORT and its inactive metabolite 11-DHC. At 242 
equal systemic CORT exposure (Fig. 6A), AR antagonism significantly decreased CORT levels in WAT 243 
(p<0.01, Fig. 6B), while this was unaltered by AR agonism. In contrast to WAT, AR antagonism did not 244 
influence hepatic CORT levels (Fig 6C). Plasma and liver levels of the inactive glucocorticoid 245 
metabolite 11-DHC were significantly increased upon AR blockade (Fig. 6D, F), but were not changed 246 
in WAT (Fig. 6E). Androgen signaling thus seems to modulate glucocorticoid turnover, as the 247 
CORT/11-DHC ratio in plasma, WAT and liver was consistently lower upon AR antagonism (Fig. 6G-I), 248 
influencing tissue-specific glucocorticoid ligand levels.  249 
AR antagonism decreases 11BHSD1 expression which underlies GR transcriptional activity in WAT 250 
but not liver 251 
The balance between active vs inactiv  glucocorticoids in the circulation is predominantly dictated 252 
by peripheral and central 11BHSD1 activity and renal 11BHSD2 activity (Pereira, et al. 2012). Local 253 
active glucocorticoid levels may however be skewed by tissue-specific 11BHSD1 activity, and to 254 
explore if this contributes to altered glucocorticoid turnover upon AR blockage we analyzed mRNA 255 
and protein expression of 11BHSD1. CORT upregulated hsd11b1 mRNA expression in WAT and liver 256 
(Fig. 7A-B). In WAT, this upregulation was accompanied by increased 11BHSD1 protein expression 257 
(Fig. 7C). Notably, this upregulation was abolished by AR blockade (p<0.05 for protein; Fig. 7C), 258 
suggesting that AR signaling influences glucocorticoid turnover in WAT. In liver, AR antagonism 259 
attenuated CORT-induced hsd11b1 mRNA expression (Fig. 7B), but protein expression did not follow 260 
this pattern (Fig. 7D). We next analyzed if altered glucocorticoid turnover contributed to the reduced 261 
GR-regulated transcriptional activity upon AR antagonism. Thereto we plotted tissue-specific CORT 262 
concentrations against GR-responsive transcript expression, revealing that Fkbp5, Gilz and Mt2a 263 
expression proportionally changed in parallel with ligand concentrations in WAT (Fig. 7E). In contrast 264 
to WAT, GR-regulated transcriptional activity in liver was altered independent of tissue CORT 265 
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concentration (Fig. 7F). Altered 11BHSD1-mediated glucocorticoid turnover thus seems to partially 266 
underlie diminished GR-regulated transcriptional activity in WAT but not in liver.  267 
 268 
Discussion 269 
In this study we set out to investigate if crosstalk between androgens and glucocorticoids exists in 270 
metabolic tissues. While glucocorticoid-androgen interactions are widely described in prostate 271 
cancer (Arora et al. 2013; Li, et al. 2017; Puhr, et al. 2018; Xie, et al. 2015), the importance for 272 
metabolic tissues has yet remained elusive. This and previously published findings that 273 
glucocorticoids can act in a sexually dimorphic manner (Duma et al. 2010; Quinn and Cidlowski 2016) 274 
prompted us to investigate the potential modulating role of androgen sex hormones in metabolic 275 
glucocorticoid signaling. In our Cushing’s-like model for excessive glucocorticoid exposure, with 276 
metabolic features comparable to human Cushing’s syndrome (Ferrau and Korbonits 2015), we 277 
observed distinct patterns of glucocorticoid-androgen crosstalk in different metabolic tissues: i.e. 278 
AR-mediated potentiation of GR signaling in WAT and BAT, and attenuated GR signaling upon AR 279 
blockade in WAT and liver.  280 
Concerning the increased GR-target gene expression upon simultaneous CORT and DHT exposure, it 281 
has to be noted that the enhanced GR-target gene expression observed upon DHT treatment may 282 
either be the consequence of AR-mediated potentiation of GR signaling or it could be an additive 283 
effect, reflecting the promiscuous nature of many GR-responsive transcripts that can also be AR-284 
responsive. Our findings in cultured white and brown adipocytes show that DHT alone does not 285 
induce Gilz and Mt2 expression, but that combined with CORT it synergistically enhances 286 
transcription. This suggests that a potentiation of GR signaling by AR is responsible for the increased 287 
transcription, rather than additive transcriptional effects of both receptors on shared GR-AR target 288 
genes. On the other hand, Fkbp5 expression was slightly induced by DHT alone. Part of the effect 289 
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could thus be mediated via direct AR-mediated transcription on this shared GR-AR target gene, 290 
possibly independent of GR (Arora et al. 2013). Nevertheless, Fkbp5 induction upon combined CORT 291 
and DHT exceeds the effect observed upon DHT alone, thus also pointing to potentiation of GR-292 
mediated Fkbp5 transcription by androgens. Aside from enhanced transcription upon DHT, we found 293 
that AR antagonism attenuates target gene expression and AR is thus required for effective GR-294 
regulated transcriptional activity. This could be a direct effect, i.e. physical presence of AR is 295 
essential to facilitate GR activity, or an indirect effect, i.e. expression of factors that modulate GR 296 
activity are AR-driven. Enzalutamide treatment could reduce expression of AR-regulated factors that 297 
are required for adequate GR activity. Since Enzalutamide prevents nuclear translocation of AR 298 
(Schalken and Fitzpatrick 2016), this argues against active physical repression of transcription by 299 
Enzalutamide-bound AR on shared GR-AR loci. 300 
Although glucocorticoids can have pleiotropic effects on WAT by stimulating both lipolysis and 301 
lipogenesis (Lee, et al. 2014), they are classically perceived as catabolic hormones (e.g. stimulating 302 
protein breakdown in skeletal muscle and decreasing bone formation) (Cohen and Steger 2017). In 303 
contrast, androgens are mainly anabolic (e.g. promoting muscle growth, formation of trabecular and 304 
cortical bone mass). Despite these seemingly opposite functions, our data suggest that both classes 305 
of steroids also have the capacity to cooperate in certain tissues. This convergence of signaling may 306 
initially support a common goal - setting free energy substrates by e.g. lipolysis (Lee et al. 2013; 307 
Peckett, et al. 2011) – but subsequently aids differential functions: energy mobilization to cope with 308 
a stressful situation for glucocorticoids and generating fuel for anabolic growth for androgens. In our 309 
studies, we indeed observe collaborative signaling between glucocorticoids and androgens in WAT – 310 
which has lipolytic capacity (Wang, et al. 2015) - but how glucocorticoid-androgen interplay affects 311 
fuel-utilizing tissues is a subject for further study.  312 
Our data indicate that androgens modulate glucocorticoid signaling via parallel, non-mutually 313 
exclusive mechanisms. We show that androgen signaling influences activity of 11BHSD isozymes, 314 
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resulting in altered systemic and tissue-specific glucocorticoid turnover. Systemically, AR antagonism 315 
increased inert glucocorticoid levels, likely due to decreased peripheral 11BHSD1 activity. It has been 316 
described that 11BHSD1-deficient tissues are shielded from glucocorticoid effects (Doig, et al. 2017; 317 
Morgan, et al. 2014). AR antagonism mimics this effect in WAT, as decreased CORT levels were 318 
found due to impaired local glucocorticoid regeneration. The decreased levels of active 319 
glucocorticoids were associated with diminished GR-regulated transcriptional activity in WAT. In liver 320 
a discrepancy was found between 11BHSD1 mRNA and protein expression, with reduced GR-321 
regulated transcriptional activity upon AR antagonism shown to be independent of glucocorticoid 322 
ligand concentration. Differential 11BHSD1 activity upon AR antagonism does thus not underlie 323 
blunted hepatic GR response. Possibly, crosstalk between GR and AR prevails at the DNA-binding 324 
level. In different peripheral tissues, distinct AR-mediated effects on glucocorticoid regulation thus 325 
underlie the reduced GR-regulated transcriptional activity. 326 
Sexual dimorphism exists in metabolic processes and affects incidence of metabolic disease. For 327 
example, expression of metabolic gene expression is highly divergent between male and female 328 
mice, particularly in the liver (Yang, et al. 2006). Although short-term fasting does not provoke many 329 
sex-specific effects in metabolic organs like WAT and muscle, the metabolic profile in the liver is 330 
greatly different between sexes (Della Torre, et al. 2018). This may in part be explained by 331 
differential exposure to sex hormones like androgens and estrogens. A direct role of androgens in 332 
the development of human cardiometabolic disease seems likely as this is more common in males 333 
versus females (Haring, et al. 2012; Yang and Kozloski 2011). Also female-to-male transgenders - in 334 
whom estrogens are replaced with androgens - present with increased body mass index and 335 
unfavorable lipid profiles (Quiros, et al. 2015; Velho, et al. 2017).  336 
We can speculate that GR-AR interactions may contribute to metabolic dysfunction associated with 337 
endocrine conditions like Cushing’s syndrome and polycystic ovary syndrome (PCOS). In PCOS 338 
patients, who are characterized by hyperandrogenism, metabolic abnormalities are remarkably 339 
Page 15 of 31
joe@bioscientifica.com
Manuscript submitted for review to Journal of Endocrinology
For Review Only
15 
 
similar to those upon excess glucocorticoid exposure (e.g. adiposity, insulin resistance) (van Houten 340 
and Visser 2014). In our current study, we exclusively used male mice. Further studies in PCOS 341 
models in female mice (van Houten, et al. 2012) are warranted to fully outline the potential role of 342 
GR-AR interactions in this endocrine disease.  343 
In our studies, most glucocorticoid-driven pathologies were found not to be androgen-dependent, 344 
with the notable exception of glucocorticoid-induced hyperlipidemia. It has to be noted however 345 
that Enzalutamide alone, independent of excessive CORT exposure, already lowered plasma lipid 346 
levels. Also, Enzalutamide treatment resulted in increased testosterone levels, which via aromatase 347 
can be converted to estradiol and provide metabolic benefit (Ohlsson, et al. 2017). Possibly a 348 
protective role of estrogens, rather than a harmful role of androgens, may thus contribute to the 349 
sexually dimorphic effects and cardiometabolic incidence. In support of this notion is that male and 350 
female mice treated with estrogens were protected from the complications of high-fat diet feeding 351 
(Dakin, et al. 2015; Kim, et al. 2014). In cancer, the estrogen receptor can also directly interact with 352 
the GR (West, et al. 2016), but it is unclear if a similar crosstalk is involved in metabolic GR signaling. 353 
Future research is thus warranted to fully establish the relative contributions of sex hormones – 354 
both androgen and estrogens – in glucocorticoid signaling and glucocorticoid-associated metabolic 355 
disease. 356 
 357 
Conclusion 358 
We show crosstalk between glucocorticoid and androgen signaling in metabolic tissues (Fig. 8). 359 
These potentially bidirectional interactions can dramatically differ between tissues, as we found 360 
distinct patterns of nuclear receptor cooperation in the three different metabolic tissues that were 361 
analyzed. Our novel findings provide a proof-of-concept that interactions between different nuclear 362 
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receptor pathways exist in metabolic tissues. Further research is warranted to outline the relative 363 
contribution of glucocorticoid-androgen crosstalk to metabolic health.  364 
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Figure legends 492 
Figure 1: Confirmation of glucocorticoid and androgen interventions 493 
The effect of Enzalutamide on (A) Testosterone-induced and (B) DHT-induced TAT3 luciferase-494 
reporter signaling, and on (C) basal and cortisol-induced GR signaling in human HEK293T cells. Data 495 
are mean±SEM and experiments were performed in quadruplicate. Statistical significance was 496 
calculated using an one-way analysis of variance. *** p<0.001 vs Veh, $$$ p<0.001 vs Test. or DHT. 497 
(D) Glucocorticoid-responsive adrenals and (E) androgen-responsive seminal vesicle organ weight in 498 
response to glucocorticoid and androgen interventions. Data are mean±SEM and N=6-7 per group. 499 
Statistical significance was calculated using a one-way analysis of variance with the Tukey multiple-500 
comparisons test. ** p<0.01 vs Vehicle, *** p<0.001 vs Vehicle, $$$ p<0.001 vs CORT. (F-H) 501 
Dihydrotestosterone (DHT) and (I-K) Testosterone concentrations in plasma, WAT and liver. Data are 502 
mean±SEM and N=6-7 per group. Statistical significance was calculated using a one-way analysis of 503 
variance with the Tukey multiple-comparisons test. * p<0.05 vs Vehicle, *** p<0.001 vs Vehicle, $ 504 
p<0.05 vs CORT, $$$ p<0.001 vs CORT.  505 
Figure 2: AR antagonism lowers glucocorticoid-induced hyperlipidemia  506 
(A) Body weight and composition and (B) plasma lipid levels of male C57BL6/J mice upon 507 
glucocorticoid and androgen interventions. Data are mean±SEM and N=6-7 per group. To calculate 508 
the change in body weight, fat and lean mass, measurements at day 14 and baseline values were 509 
used. Statistical significance was calculated using a one-way analysis of variance with the Tukey 510 
multiple-comparisons test. * p<0.05 vs Vehicle, ** p<0.01 vs Vehicle, *** p<0.001 vs Vehicle, $ 511 
p<0.05 vs CORT, $$ p<0.01 vs CORT, $$$ p<0.001 vs CORT. (C) Body weight and composition and (D) 512 
plasma lipid levels of male C57BL6/J mice upon Enzalutamide treatment. Data are mean±SEM and 513 
N=6 per group. To calculate the change in body weight, fat and lean mass, measurements at day 27 514 
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and baseline values were used. Statistical significance was calculated using a unpaired students t-515 
test. ** p<0.01 vs Vehicle, *** p<0.001 vs Vehicle. 516 
Figure 3: AR signaling regulates GR-regulated transcriptional activity in metabolic tissues 517 
(A-C) WAT, (D-F) liver, (G-I) and BAT mRNA expression of GR-responsive genes Fkbp5, Gilz and Mt2a. 518 
Data are mean±SEM and N=6-7 per group. Statistical significance was calculated using a one-way 519 
analysis of variance with the Tukey multiple-comparisons test. * p<0.05 vs Vehicle, ** p<0.01 vs 520 
Vehicle, *** p<0.001 vs Vehicle, $ p<0.05 vs CORT, $$ p<0.01 vs CORT. (J) WAT and (K) liver FKBP5 521 
protein expression. Representative Western images are shown and quantification of protein 522 
expression is based on N=6 per group. Data are mean±SEM and statistical significance was calculated 523 
using a one-way analysis of variance with the Tukey multiple-comparisons test. * p<0.05 vs Vehicle, 524 
** p<0.01 vs Vehicle, *** p<0.001 vs Vehicle, $ p<0.05 vs CORT. (L) Expression of genes involved in 525 
WAT lipolysis, liver VLDL-production and BAT thermogenesis. * p<0.05 vs Vehicle, $ p<0.05 vs CORT. 526 
(M-N) The effect of Enzalutamide treatment in vivo on WAT and liver gene expression. Statistical 527 
significance was calculated by unpaired students t-test. 528 
Figure 4: AR signaling potentiates GR-regulated transcriptional activity in murine white and brown 529 
adipocytes 530 
(A-B) Nr3c1 and Nr3c4 expression in murine 3T3.L1 white adipocytes and cultured brown adipocytes. 531 
Data are mean±SEM and N=3 per group. (C-F) Murine 3T3.L1 white adipocyte mRNA expression of 532 
GR-responsive genes Fkbp5, Gilz and Mt2a and lipolysis gene Atgl upon exposure to 10-30 nM 533 
corticosterone and 100 nM dihydrotestosterone (DHT). (G-J) Brown adipocyte mRNA expression of 534 
GR-responsive genes Fkbp5, Gilz and Mt2a and thermogenic gene Ucp1 upon exposure to 10-30 nM 535 
corticosterone and 100 nM dihydrotestosterone (DHT). Data are mean±SEM and experiments were 536 
performed in quadruplicate or quintuplicate. Statistical analysis was calculated with an unpaired 537 
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students t-test for each CORT dose comparing with and without DHT treatment. * p<0.05 vs Vehicle, 538 
** p<0.01 vs Vehicle, *** p<0.001 vs Vehicle. 539 
Fig 5: GR expression in WAT and liver 540 
(A-D) WAT and liver Nr3c1 mRNA expression and GR protein expression upon glucocorticoid and 541 
androgen interventions. For RT-PCR data are mean±SEM and N=6-7 per group. Statistical significance 542 
was calculated using a one-way analysis of variance with the Tukey multiple-comparisons test. 543 
Representative Western images are shown and quantification of protein expression is based on N=6 544 
per group. GAPDH loading controls are identical to the ones shown in Fig. 3J-K. Statistical 545 
significance was calculated using a one-way analysis of variance with the Tukey multiple-546 
comparisons test. ** p<0.01 vs Vehicle, *** p<0.001 vs Vehicle.  547 
Figure 6: AR signaling modulates systemic and tissue-specific glucocorticoid turnover 548 
(A-C) Concentrations of corticosterone (CORT) and (D-F) 11-dehydrocorticosterone (11-DHC), and (G-549 
I) the ratio between CORT/11-DHC in plasma, WAT and liver. Data are mean±SEM and N=6-7 per 550 
group. Statistical significance was calculated using a one-way analysis of variance with the Tukey 551 
multiple-comparisons test. * p<0.05 vs Vehicle, ** p<0.01 vs Vehicle, *** p<0.001 vs Vehicle, $ 552 
p<0.05 vs CORT, $$ p<0.01 vs CORT. 553 
Figure 7: AR signaling modulates 11BHSD1 and contributes to GR-regulated transcriptional activity 554 
in WAT but not liver 555 
(A-D) Hsd11b1 mRNA and 11BHSD1 protein expression in WAT and liver upon glucocorticoid and 556 
androgen interventions. (E-F) The relationship between CORT levels and the expression of GR-557 
responsive genes Fkbp5, Gilz and Mt2a in WAT and liver. Data are mean±SEM and N=6-7 per group. 558 
Statistical significance was calculated using a one-way analysis of variance with the Tukey multiple-559 
comparisons test. * p<0.05 vs Vehicle, ** p<0.01 vs Vehicle, $ p<0.05 vs CORT, $$ p<0.01 vs CORT. 560 
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Representative Western images are shown and quantification of protein expression is based on 6 561 
per group. GAPDH loading controls in Fig. 7D are identical to the ones shown in Fig. 3K.  562 
Figure 8: Schematic overview of glucocorticoid-androgen crosstalk in WAT, liver and BAT. 563 
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